Doxorubicin (Lamnotherapeutics)

N/A

Report date: 2026/01/26 13:50:13

Base Information

Drug NameDoxorubicin (Lamnotherapeutics)
Drug Alias Namesmart nano-DOX incorporated with LXY3 (Lamnotherapeutics)smart nano-doxorubicin incorporated with LXY3 (Lamnotherapeutics)Doxorubicin
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Anthracycline antibiotics
Mechanisms of ActionVirus DNA polymerase inhibitorsTopoisomerase II inhibitorsDNA intercalators
TargetsVirus DNA polymeraseDNATopoisomerase II
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLamnotherapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLamnotherapeutics Inc
Active IndicationsN/A
Inactive IndicationsBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A